- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Autoimmune Bullous Dermatosis in New Zealand
Total 2303 results
-
Premier Specialists, AustraliaSteritasActive, not recruitingGlucocorticoids Toxicity | Autoimmune Bullous DermatosisAustralia
-
Tavotek BiotherapeuticsRecruiting
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
argenxActive, not recruitingBullous PemphigoidUnited States, Australia, Bulgaria, China, Croatia, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Latvia, Netherlands, Poland, Romania, Serbia, Slovakia, Spain, United Kingdom
-
Regeneron PharmaceuticalsSanofiActive, not recruitingBullous PemphigoidUnited States, Japan, Germany, Australia, France, Israel, Poland, Spain, Taiwan
-
Aclaris Therapeutics, Inc.CompletedDermatosis Papulosa NigraUnited States
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
Ribon Therapeutics, Inc.RecruitingAtopic DermatitisAustralia, New Zealand
-
Coegin Pharma ABBispebjerg Hospital; Studies&MeActive, not recruiting
-
Immune PharmaceuticalsCompletedPemphigoid, BullousUnited States, Israel
-
Diatranz Otsuka LimitedCompleted
-
Arrowhead PharmaceuticalsRecruitingIgA NephropathyNew Zealand
-
Zenas BioPharma (USA), LLCActive, not recruitingRheumatoid Arthritis | Healthy VolunteersNew Zealand, Australia
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsEnrolling by invitationNeurobehavioral Manifestations | Allergy | Microbial Colonization | Growth Disorders | Atopic Dermatitis | Obesity, Childhood | Metabolic Disturbance | Cognition | Lifestyle | Breastfeeding | Nutrition, Healthy | AtopySingapore, United Kingdom, New Zealand
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
PeplinCompletedActinic KeratosesAustralia, New Zealand
-
Zealand University HospitalUniversity of Copenhagen; Danish Working Environment FundCompleted
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, New Zealand, Australia
-
University of Auckland, New ZealandCounties Manukau Health; Auckland Medical Research Foundation; Auckland District... and other collaboratorsUnknown
-
Visterra, Inc.TerminatedAutoimmune DiseasesNew Zealand, Germany, Bulgaria, Moldova, Republic of, Netherlands
-
Syneos HealthDr. Reddy's Laboratories LimitedCompletedRheumatoid Arthritis | Giant Cell ArteritisNew Zealand, Australia, India
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
Lenus Therapeutics, LLCTerminatedDystrophic Epidermolysis Bullosa | Junctional Epidermolysis BullosaUnited States
-
Columbia UniversityTerminatedEpidermolysis BullosaUnited States
-
Gilead SciencesGalapagos NVCompletedRheumatoid ArthritisUnited States, Germany, New Zealand
-
Phoenix Tissue Repair, Inc.Phoenix Tissue Repair, a BridgeBio companyCompletedRecessive Dystrophic Epidermolysis BullosaUnited States
-
Patel, Rita Vikram, M.D.Ranbaxy Inc.CompletedAcute Steroid Responsive Dermatoses | Chronic Steroid Responsive DermatosesUnited States
-
PfizerTerminatedHealthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune ThrombocytopeniaSpain, United States, Belgium, United Kingdom, New Zealand
-
Akesobio Australia Pty LtdRecruitingPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisAtopic DermatitisUnited States, Australia, New Zealand
-
Rockefeller UniversityWashington University School of Medicine; Tel Aviv UniversityCompleted
-
OrganogenesisTerminatedEpidermolysis Bullosa Dystrophica | Epidermolysis Bullosa, JunctionalUnited States
-
Botanix PharmaceuticalsCompletedAtopic DermatitisUnited States, Australia, New Zealand
-
BayerCompleted
-
PeplinCompletedSeborrheic KeratosisAustralia
-
MedImmune LLCAmgenCompletedAtopic DermatitisUnited States, Germany, New Zealand, Hungary, Australia, Canada
-
MC2 TherapeuticsCompletedPhototoxicityUnited States
-
Melbourne HealthCompletedType 1 DiabetesAustralia, New Zealand
-
Novartis PharmaceuticalsCompletedHealthy Volunteers | Atopic Dermatitis | Netherton SyndromeNetherlands, United States
-
Professor Michael BourkeRecruitingAdenoma, VillousAustralia
-
Icahn School of Medicine at Mount SinaiBausch Health Americas, Inc.CompletedActinic KeratosisUnited States
-
Bausch & Lomb IncorporatedBausch Health Americas, Inc.CompletedTinea Pedis | Tinea CrurisUnited States
-
Dartmouth-Hitchcock Medical CenterNorris Cotton Cancer CenterCompleted